| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 42.333 | 51.417 | 57.177 | 54.203 | 62.393 | 79.603 | 89.425 |
| Total Income - EUR | - | - | - | 42.334 | 51.419 | 57.178 | 54.206 | 62.396 | 79.606 | 89.429 |
| Total Expenses - EUR | - | - | - | 15.398 | 17.874 | 26.847 | 29.608 | 31.038 | 32.157 | 31.934 |
| Gross Profit/Loss - EUR | - | - | - | 26.936 | 33.545 | 30.332 | 24.597 | 31.358 | 47.449 | 57.495 |
| Net Profit/Loss - EUR | - | - | - | 26.514 | 33.031 | 29.976 | 24.066 | 30.734 | 46.703 | 54.866 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Covacic Tünde Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 557 | 505 | 1.697 | 1.415 |
| Current Assets | - | - | - | 27.159 | 33.756 | 32.646 | 25.851 | 33.167 | 49.762 | 59.069 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 7.782 | 4.854 | 16.021 | 12.002 | 22.807 | 22.583 | 38.148 |
| Cash | - | - | - | 19.377 | 28.902 | 16.624 | 13.849 | 10.360 | 27.179 | 20.921 |
| Shareholders Funds | - | - | - | 26.106 | 33.082 | 30.025 | 24.115 | 30.783 | 46.752 | 54.914 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.053 | 675 | 2.620 | 2.293 | 2.889 | 4.707 | 5.569 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Covacic Tünde Srl